PEN-866 in Patients With Advanced Solid Malignancies
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Protocol PEN-866-001 is an open-label, multi-center, first-in-human Phase 1/2a study
evaluating PEN-866 in patients with advanced solid malignancies whose disease has progressed
after treatment with previous anticancer therapies.